The cardioprotective properties of adiponectin has been established recently in obesity-related diseases, including hypertrophic cardiomyopathy, myocardial ischemia–reperfusion injury, and heart failure [10]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.